Global Obesity Drugs Market valued at $2.3 billion (2022), is Projected to Witness a Significant Growth Rate of 25% by 2027
23 janv. 2023 09h30 HE
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by...
Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz
07 sept. 2016 08h00 HE
|
Researchmoz Global Pvt Ltd
Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...